Besides the acute phase gastrointestinal effects which may lead to up to 10% of people discontinuing the drugs, there are other potential GI side effects of obstruction, excessive loss of muscle mass, and potentially association with some eye disease adverse events
For experimental workflows, Retatrutide is available in multiple formats designed to support different research scales
[7] Nutritional support is a priority
The program is billed as a monthly subscription with payments charged automatically at the billing cycle
Retatrutide is the first peptide to combine GLP-1, GIP, and glucagon receptor agonism in a single molecule
Weeks 1-4: Listen to Your Body Youll begin with a low dose of 0.2mg, or 8 units on the syringe, which is about the lowest measurement